| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/21/2006 | US20060211141 Protein biopolymer markers predictive of insulin resistance |
| 09/21/2006 | US20060211140 Protein biopolymer markers predictive of insulin resistance |
| 09/21/2006 | US20060211139 Protein biopolymer markers predictive of insulin resistance |
| 09/21/2006 | US20060211138 Protein biopolymer markers predictive of insulin resistance |
| 09/21/2006 | US20060211137 Biosensor |
| 09/21/2006 | US20060211136 Method for gold deposition |
| 09/21/2006 | US20060211135 Method and apparatus for separating molecules using micro-channel |
| 09/21/2006 | US20060211131 Method for analysis of contaminants in a process fluid stream |
| 09/21/2006 | US20060211127 Blood testing unit and blood testing method and apparatus |
| 09/21/2006 | US20060211124 Method for the determination of the CaCO3 content of a scrubbing liquid |
| 09/21/2006 | US20060211123 Sensing element and method of making |
| 09/21/2006 | US20060211122 Reagents for the measurement of peroxynitrites |
| 09/21/2006 | US20060211121 Impregnating a layer with a solvent, applying the compound of interest on the impregnated layer, adding octanol; removing the solvent after the distribution equilibrium has been reached; determining the quantity of the compound of interest in the solvent phase |
| 09/21/2006 | US20060211120 verifying authenticity of a preparation by detecting a tracer by precipitating a coloring agent from a sample, where the coloring agent otherwise interferes with detection of the tracer; authentication, process or quality control, or detecting counterfeits; detecting food dyes in beverages for example |
| 09/21/2006 | US20060211119 Fuel cell leak detection |
| 09/21/2006 | US20060211114 Modulation of hedgehog-mediated signaling pathway |
| 09/21/2006 | US20060211106 Test specimen and production thereof |
| 09/21/2006 | US20060211093 Membrane scaffold proteins and embedded membrane proteins |
| 09/21/2006 | US20060211092 Membrane scaffold proteins and tethered membrane proteins |
| 09/21/2006 | US20060211090 Human cDNAs and proteins and uses thereof |
| 09/21/2006 | US20060211077 Methods and compositions to diagnose disease using concatenated oligopeptide standard |
| 09/21/2006 | US20060211076 Method and device for the qualitative and/or quantitative determination of a protein and/or peptide pattern of a fluid sample, which has been taken from a human or animal body |
| 09/21/2006 | US20060211070 Polyclonal-polyclonal ELISA assay for detecting N-terminus-proBNP |
| 09/21/2006 | US20060211069 Device including a proteinaceous factor, a recombinant proteinaceous factor, and a nucleotide sequence encoding the proteinaceous factor |
| 09/21/2006 | US20060211068 Device including a proteinaceous factor, a recombinant proteinaceous factor, and a nucleotide sequence encoding the proteinaceous factor |
| 09/21/2006 | US20060211067 Device including a proteinaceous factor, a recombinant proteinaceous factor, and a nucleotide sequence encoding the proteinaceous factor |
| 09/21/2006 | US20060211066 Device including a proteinaceous factor, a recombinant proteinaceous factor, and a nucleotide sequence encoding the proteinaceous factor |
| 09/21/2006 | US20060211065 Device including a proteinaceous factor, a recombinant proteinaceous factor, and a nucleotide sequence encoding the proteinaceous factor |
| 09/21/2006 | US20060211064 Detection of hypertension using glucuronidated metabolic products |
| 09/21/2006 | US20060211063 Phosphokinase assay |
| 09/21/2006 | US20060211062 Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies |
| 09/21/2006 | US20060211061 Linking via an antibody a magnetic microparticle to an epitope of the target microorganism; magnetically separating the magnetic microparticle and linked targeted microorganism from other components; linking a glucose molecule to a second epitope of the microorganism; detecting the glucose in the test |
| 09/21/2006 | US20060211060 Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors |
| 09/21/2006 | US20060211059 Methods of improving screening, diagnosis and staging of prostate cancer using serum testosterone |
| 09/21/2006 | US20060211058 Diagnosis and treatment of malignant neoplasms |
| 09/21/2006 | US20060211057 Methods and compounds for promoting vessel regression |
| 09/21/2006 | US20060211056 Leishmania antigens suitable for a diagnostic kit of Leishmania |
| 09/21/2006 | US20060211055 Capture and release assay system and method |
| 09/21/2006 | US20060211054 Using multi-immunoglobulin screening to preferentially discriminate between active (non-reduced) human parathyroid hormone and reduced parathyroid hormone in physiological sample; oxidative stress and dialysis |
| 09/21/2006 | US20060211053 Selecting therapeutic human monoclonal antibodies for disease-specific libraries |
| 09/21/2006 | US20060211052 Screening antibodies using an optical fiber array device capable of simultaneously performing multiple functional assays |
| 09/21/2006 | US20060211051 Methods and reagents for preparing and using immunological agents specific for p-glycoprotein |
| 09/21/2006 | US20060211050 Methods of using 18903 to treat pain and pain-related disorders |
| 09/21/2006 | US20060211049 Estrogen related receptor, ERRalpha, a regulator of bone formation |
| 09/21/2006 | US20060211048 Biopolymer marker indicative of disease state having a molecular weight of 1211 daltons |
| 09/21/2006 | US20060211047 Test kit |
| 09/21/2006 | US20060211046 Bacterial ligand-binding sensor |
| 09/21/2006 | US20060211045 Fluorescently tagged ligands |
| 09/21/2006 | US20060211044 Translucent solid matrix assay device dor microarray analysis |
| 09/21/2006 | US20060211043 Ability to bind to an insect molting hormone such as ecdysteroid; used as insect growth inhibitor is effective for the development of a disinfestant |
| 09/21/2006 | US20060211042 Methods of identifying modulators of cellular glycosylation using gtrap3-18 |
| 09/21/2006 | US20060211041 Protein binding to akt2 |
| 09/21/2006 | US20060211039 LDL receptor signaling pathways |
| 09/21/2006 | US20060211038 Methods for detecting vasculopathies and tumors |
| 09/21/2006 | US20060211035 Kits for predicting transplant rejection |
| 09/21/2006 | US20060211034 Nucleic acid archiving |
| 09/21/2006 | US20060211031 Novel proteins and nucleic acids encoding same |
| 09/21/2006 | US20060211022 Detection of compounds that affect therapeutic activity |
| 09/21/2006 | US20060211020 Methods for the diagnosis, prognosis and treatment of metabolic syndrome |
| 09/21/2006 | US20060211017 Expression profile of prostate cancer |
| 09/21/2006 | US20060211015 detecting a difference between the levels of an expression product of a cancer associated (CA) gene in a cell in the presence and absence of an anticancer drug candidate; for carcinomas, especially lymphoma carcinomas |
| 09/21/2006 | US20060211013 Method for sorting antifungal molecules acting on the glucanosyltransferase activity |
| 09/21/2006 | US20060211011 making multiple substantial replicas of a biomolecular content of a multi-well sample holder; provided parallel systems enhance scientific accuracy by eliminating variability inherent in testing separate multi-well plates, and avoids much of the time and expense of preparing and screening multiple plates |
| 09/21/2006 | US20060211010 Separating an intact nucleotide phosphate probe from a phosphate detectable moiety using enzymes; DNA sequencing |
| 09/21/2006 | US20060211007 Ligand/binding partner bio-labeling systems |
| 09/21/2006 | US20060211005 Method of measuring pyrophosphate and method of detecting primer extension reaction, and device for performing the same |
| 09/21/2006 | US20060211004 Methods and compositions for determining non-specific cytotoxicity of a transfection agent |
| 09/21/2006 | US20060210996 Methods for in situ generation of chemical arrays |
| 09/21/2006 | US20060210989 Screening process for hydantoin racemases |
| 09/21/2006 | US20060210987 Method for the spatially resolved determination of physcial, chemical and/or biological properties or state variables |
| 09/21/2006 | US20060210985 Dna fragment amplification method, reaction apparatus for amplifying dna fragment and process for producing the same |
| 09/21/2006 | US20060210984 Use of nucleic acid mimics for internal reference and calibration in a flow cell microarray binding assay |
| 09/21/2006 | US20060210982 Cleavable assigned molecules and screening method using the same |
| 09/21/2006 | US20060210978 Proteome-wide mapping of post-translational modifications using endopeptidases |
| 09/21/2006 | US20060210975 Secreted and cytoplasmic tumor endothelial markers |
| 09/21/2006 | US20060210974 Compositions and methods for preventing, treating and diagnosing diabetes |
| 09/21/2006 | US20060210973 Inhibitors of proteins from the rho-gef family |
| 09/21/2006 | US20060210970 Methods, compositions and kits for biomarker extraction |
| 09/21/2006 | US20060210964 Prevention and treatment of amyloid-associated disorders |
| 09/21/2006 | US20060210655 Bioactive compositions, natural methods of producing them and computational methods for designing natural production processes |
| 09/21/2006 | US20060210647 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto |
| 09/21/2006 | US20060210590 Minor allergen control to increase safety of immunotherapy |
| 09/21/2006 | US20060210587 Virus-like particles for the induction of autoantibodies |
| 09/21/2006 | US20060210583 Nucleic acids encoding Sarcocystis neurona antigen and uses thereof |
| 09/21/2006 | US20060210578 Immunogenic polypeptide isolated from mycobacterium avium subspecies paratuberculosis and uses therof |
| 09/21/2006 | US20060210577 isolated nucleic acid molecule encoding polypeptide as antitumor biodrugs; monoclonal antibody; modulation of chemokine, cytokine expression; transfected host cell; anticarcinogenic agents |
| 09/21/2006 | US20060210576 Method for treating or preventing metastasis of colorectal cancers |
| 09/21/2006 | US20060210575 Cytotoxic protein and utilization thereof |
| 09/21/2006 | US20060210573 Containing one or more epitopes recognized by and binding to a BAT monoclonal antibody; diagnosing and treating cancer; cancer vaccines; monoclonal, polyclonal, recombinant, synthetic intact antibody and Fv, F(ab'), F(ab')2 and single chain antibody fragments; polynucleotides |
| 09/21/2006 | US20060210571 Engineering antibodies that bind irreversibly |
| 09/21/2006 | US20060210565 Antagonists of HMG1 for treating inflammatory conditions |
| 09/21/2006 | US20060210560 TNF receptor action modulaton |
| 09/21/2006 | US20060210559 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 09/21/2006 | US20060210556 Novel composition and methods for the treatment of immune disorders |
| 09/21/2006 | US20060210554 Detection of cholesterol ozonation products |
| 09/21/2006 | US20060210452 Very large scale immobilized polymer synthesis |
| 09/21/2006 | US20060210438 Sample analyzer and sample analyzing method |
| 09/21/2006 | US20060210436 Nematic liquid crystal thin films for chemical vapor sensing |
| 09/21/2006 | US20060210434 Matrix storage and dispensing system |
| 09/21/2006 | US20060210433 Signal measuring system having a movable signal measuring device |